Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/prod-to-govt-for-daily-pills-for-tb-patients-4675626/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/prod-to-govt-for-daily-pills-for-tb-patients-4675626/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/prod-to-govt-for-daily-pills-for-tb-patients-4675626/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/prod-to-govt-for-daily-pills-for-tb-patients-4675626/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6e9a791571-trace').style.display = (document.getElementById('cakeErr67f6e9a791571-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f6e9a791571-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6e9a791571-code').style.display = (document.getElementById('cakeErr67f6e9a791571-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6e9a791571-context').style.display = (document.getElementById('cakeErr67f6e9a791571-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f6e9a791571-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f6e9a791571-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 27575,
		&#039;title&#039; =&gt; &#039;Prod to govt for daily pills for TB patients&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 March, 2015, http://www.telegraphindia.com/1150321/jsp/nation/story_10034.jsp#.VQzbtOFr9U8&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;prod-to-govt-for-daily-pills-for-tb-patients-4675626&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4675626,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 27575,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Prod to govt for daily pills for TB patients&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Multi-drug-resistant Tuberculosis (MDR-TB),mdr tb,MDR-TB,healthcare,healthcare in india,Tuberculosis,TB,Public Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph


New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.


Although the health ministry had itself last year released TB...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 27575,
	&#039;title&#039; =&gt; &#039;Prod to govt for daily pills for TB patients&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 March, 2015, http://www.telegraphindia.com/1150321/jsp/nation/story_10034.jsp#.VQzbtOFr9U8&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;prod-to-govt-for-daily-pills-for-tb-patients-4675626&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4675626,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 27575
$metaTitle = &#039;LATEST NEWS UPDATES | Prod to govt for daily pills for TB patients&#039;
$metaKeywords = &#039;Multi-drug-resistant Tuberculosis (MDR-TB),mdr tb,MDR-TB,healthcare,healthcare in india,Tuberculosis,TB,Public Health&#039;
$metaDesc = &#039;
-The Telegraph


New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.


Although the health ministry had itself last year released TB...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/prod-to-govt-for-daily-pills-for-tb-patients-4675626.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Prod to govt for daily pills for TB patients | Im4change.org</title>
    <meta name="description" content="
-The Telegraph


New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.


Although the health ministry had itself last year released TB..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Prod to govt for daily pills for TB patients</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><em>New Delhi:</em> Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.</p><p align="justify">Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.</p><p align="justify">A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients' interests.</p><p align="justify">&quot;We're asking for something that has been adopted by almost all countries but India,&quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.</p><p align="justify">&quot;We're wondering when the health ministry will roll this out.&quot;</p><p align="justify">Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.</p><p align="justify">Almost all those who seek private treatment - an estimated half of India's TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &quot;intermittent therapy&quot;.</p><p align="justify">While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.</p><p align="justify">The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.</p><p align="justify">&quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.</p><p align="justify">&quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&quot;</p><p align="justify">An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.</p><p align="justify">A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.</p><p align="justify">The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.</p><p align="justify">The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.</p><p align="justify">&quot;When quality is assured, fixed-dose-combinations are preferable,&quot; said Swaminathan.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6e9a791571-trace').style.display = (document.getElementById('cakeErr67f6e9a791571-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f6e9a791571-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6e9a791571-code').style.display = (document.getElementById('cakeErr67f6e9a791571-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6e9a791571-context').style.display = (document.getElementById('cakeErr67f6e9a791571-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f6e9a791571-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f6e9a791571-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 27575,
		&#039;title&#039; =&gt; &#039;Prod to govt for daily pills for TB patients&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 March, 2015, http://www.telegraphindia.com/1150321/jsp/nation/story_10034.jsp#.VQzbtOFr9U8&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;prod-to-govt-for-daily-pills-for-tb-patients-4675626&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4675626,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 27575,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Prod to govt for daily pills for TB patients&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Multi-drug-resistant Tuberculosis (MDR-TB),mdr tb,MDR-TB,healthcare,healthcare in india,Tuberculosis,TB,Public Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph


New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.


Although the health ministry had itself last year released TB...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 27575,
	&#039;title&#039; =&gt; &#039;Prod to govt for daily pills for TB patients&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 March, 2015, http://www.telegraphindia.com/1150321/jsp/nation/story_10034.jsp#.VQzbtOFr9U8&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;prod-to-govt-for-daily-pills-for-tb-patients-4675626&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4675626,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 27575
$metaTitle = &#039;LATEST NEWS UPDATES | Prod to govt for daily pills for TB patients&#039;
$metaKeywords = &#039;Multi-drug-resistant Tuberculosis (MDR-TB),mdr tb,MDR-TB,healthcare,healthcare in india,Tuberculosis,TB,Public Health&#039;
$metaDesc = &#039;
-The Telegraph


New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.


Although the health ministry had itself last year released TB...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/prod-to-govt-for-daily-pills-for-tb-patients-4675626.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Prod to govt for daily pills for TB patients | Im4change.org</title>
    <meta name="description" content="
-The Telegraph


New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.


Although the health ministry had itself last year released TB..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Prod to govt for daily pills for TB patients</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><em>New Delhi:</em> Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.</p><p align="justify">Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.</p><p align="justify">A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients' interests.</p><p align="justify">&quot;We're asking for something that has been adopted by almost all countries but India,&quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.</p><p align="justify">&quot;We're wondering when the health ministry will roll this out.&quot;</p><p align="justify">Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.</p><p align="justify">Almost all those who seek private treatment - an estimated half of India's TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &quot;intermittent therapy&quot;.</p><p align="justify">While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.</p><p align="justify">The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.</p><p align="justify">&quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.</p><p align="justify">&quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&quot;</p><p align="justify">An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.</p><p align="justify">A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.</p><p align="justify">The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.</p><p align="justify">The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.</p><p align="justify">&quot;When quality is assured, fixed-dose-combinations are preferable,&quot; said Swaminathan.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6e9a791571-trace').style.display = (document.getElementById('cakeErr67f6e9a791571-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f6e9a791571-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6e9a791571-code').style.display = (document.getElementById('cakeErr67f6e9a791571-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6e9a791571-context').style.display = (document.getElementById('cakeErr67f6e9a791571-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f6e9a791571-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f6e9a791571-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 27575,
		&#039;title&#039; =&gt; &#039;Prod to govt for daily pills for TB patients&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 March, 2015, http://www.telegraphindia.com/1150321/jsp/nation/story_10034.jsp#.VQzbtOFr9U8&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;prod-to-govt-for-daily-pills-for-tb-patients-4675626&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4675626,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 27575,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Prod to govt for daily pills for TB patients&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Multi-drug-resistant Tuberculosis (MDR-TB),mdr tb,MDR-TB,healthcare,healthcare in india,Tuberculosis,TB,Public Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph


New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.


Although the health ministry had itself last year released TB...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 27575,
	&#039;title&#039; =&gt; &#039;Prod to govt for daily pills for TB patients&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 March, 2015, http://www.telegraphindia.com/1150321/jsp/nation/story_10034.jsp#.VQzbtOFr9U8&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;prod-to-govt-for-daily-pills-for-tb-patients-4675626&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4675626,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 27575
$metaTitle = &#039;LATEST NEWS UPDATES | Prod to govt for daily pills for TB patients&#039;
$metaKeywords = &#039;Multi-drug-resistant Tuberculosis (MDR-TB),mdr tb,MDR-TB,healthcare,healthcare in india,Tuberculosis,TB,Public Health&#039;
$metaDesc = &#039;
-The Telegraph


New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.


Although the health ministry had itself last year released TB...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;New Delhi:&lt;/em&gt; Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients&#039; interests.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re asking for something that has been adopted by almost all countries but India,&amp;quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;re wondering when the health ministry will roll this out.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Almost all those who seek private treatment - an estimated half of India&#039;s TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &amp;quot;intermittent therapy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&amp;quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;When quality is assured, fixed-dose-combinations are preferable,&amp;quot; said Swaminathan.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/prod-to-govt-for-daily-pills-for-tb-patients-4675626.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Prod to govt for daily pills for TB patients | Im4change.org</title>
    <meta name="description" content="
-The Telegraph


New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.


Although the health ministry had itself last year released TB..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Prod to govt for daily pills for TB patients</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><em>New Delhi:</em> Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.</p><p align="justify">Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.</p><p align="justify">A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients' interests.</p><p align="justify">&quot;We're asking for something that has been adopted by almost all countries but India,&quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.</p><p align="justify">&quot;We're wondering when the health ministry will roll this out.&quot;</p><p align="justify">Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.</p><p align="justify">Almost all those who seek private treatment - an estimated half of India's TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &quot;intermittent therapy&quot;.</p><p align="justify">While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.</p><p align="justify">The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.</p><p align="justify">&quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.</p><p align="justify">&quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&quot;</p><p align="justify">An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.</p><p align="justify">A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.</p><p align="justify">The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.</p><p align="justify">The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.</p><p align="justify">&quot;When quality is assured, fixed-dose-combinations are preferable,&quot; said Swaminathan.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 27575,
		'title' => 'Prod to govt for daily pills for TB patients',
		'subheading' => '',
		'description' => '<div align="justify">
-The Telegraph
</div>
<p align="justify">
<em>New Delhi:</em> Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.
</p>
<p align="justify">
Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.
</p>
<p align="justify">
A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients' interests.
</p>
<p align="justify">
&quot;We're asking for something that has been adopted by almost all countries but India,&quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.
</p>
<p align="justify">
&quot;We're wondering when the health ministry will roll this out.&quot;
</p>
<p align="justify">
Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.
</p>
<p align="justify">
Almost all those who seek private treatment - an estimated half of India's TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &quot;intermittent therapy&quot;.
</p>
<p align="justify">
While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.
</p>
<p align="justify">
The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.
</p>
<p align="justify">
&quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.
</p>
<p align="justify">
&quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&quot;
</p>
<p align="justify">
An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.
</p>
<p align="justify">
A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.
</p>
<p align="justify">
The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.
</p>
<p align="justify">
The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.
</p>
<p align="justify">
&quot;When quality is assured, fixed-dose-combinations are preferable,&quot; said Swaminathan.
</p>',
		'credit_writer' => 'The Telegraph, 21 March, 2015, http://www.telegraphindia.com/1150321/jsp/nation/story_10034.jsp#.VQzbtOFr9U8',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'prod-to-govt-for-daily-pills-for-tb-patients-4675626',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4675626,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 27575,
	'metaTitle' => 'LATEST NEWS UPDATES | Prod to govt for daily pills for TB patients',
	'metaKeywords' => 'Multi-drug-resistant Tuberculosis (MDR-TB),mdr tb,MDR-TB,healthcare,healthcare in india,Tuberculosis,TB,Public Health',
	'metaDesc' => '
-The Telegraph


New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.


Although the health ministry had itself last year released TB...',
	'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><em>New Delhi:</em> Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.</p><p align="justify">Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.</p><p align="justify">A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients' interests.</p><p align="justify">&quot;We're asking for something that has been adopted by almost all countries but India,&quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.</p><p align="justify">&quot;We're wondering when the health ministry will roll this out.&quot;</p><p align="justify">Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.</p><p align="justify">Almost all those who seek private treatment - an estimated half of India's TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &quot;intermittent therapy&quot;.</p><p align="justify">While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.</p><p align="justify">The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.</p><p align="justify">&quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.</p><p align="justify">&quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&quot;</p><p align="justify">An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.</p><p align="justify">A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.</p><p align="justify">The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.</p><p align="justify">The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.</p><p align="justify">&quot;When quality is assured, fixed-dose-combinations are preferable,&quot; said Swaminathan.</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 27575,
	'title' => 'Prod to govt for daily pills for TB patients',
	'subheading' => '',
	'description' => '<div align="justify">
-The Telegraph
</div>
<p align="justify">
<em>New Delhi:</em> Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.
</p>
<p align="justify">
Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.
</p>
<p align="justify">
A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients' interests.
</p>
<p align="justify">
&quot;We're asking for something that has been adopted by almost all countries but India,&quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.
</p>
<p align="justify">
&quot;We're wondering when the health ministry will roll this out.&quot;
</p>
<p align="justify">
Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.
</p>
<p align="justify">
Almost all those who seek private treatment - an estimated half of India's TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &quot;intermittent therapy&quot;.
</p>
<p align="justify">
While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.
</p>
<p align="justify">
The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.
</p>
<p align="justify">
&quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.
</p>
<p align="justify">
&quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&quot;
</p>
<p align="justify">
An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.
</p>
<p align="justify">
A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.
</p>
<p align="justify">
The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.
</p>
<p align="justify">
The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.
</p>
<p align="justify">
&quot;When quality is assured, fixed-dose-combinations are preferable,&quot; said Swaminathan.
</p>',
	'credit_writer' => 'The Telegraph, 21 March, 2015, http://www.telegraphindia.com/1150321/jsp/nation/story_10034.jsp#.VQzbtOFr9U8',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'prod-to-govt-for-daily-pills-for-tb-patients-4675626',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4675626,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {},
		(int) 6 => object(Cake\ORM\Entity) {},
		(int) 7 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 27575
$metaTitle = 'LATEST NEWS UPDATES | Prod to govt for daily pills for TB patients'
$metaKeywords = 'Multi-drug-resistant Tuberculosis (MDR-TB),mdr tb,MDR-TB,healthcare,healthcare in india,Tuberculosis,TB,Public Health'
$metaDesc = '
-The Telegraph


New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.


Although the health ministry had itself last year released TB...'
$disp = '<div align="justify">-The Telegraph</div><p align="justify"><em>New Delhi:</em> Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment.</p><p align="justify">Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse.</p><p align="justify">A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients' interests.</p><p align="justify">&quot;We're asking for something that has been adopted by almost all countries but India,&quot; said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency.</p><p align="justify">&quot;We're wondering when the health ministry will roll this out.&quot;</p><p align="justify">Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure.</p><p align="justify">Almost all those who seek private treatment - an estimated half of India's TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising &quot;intermittent therapy&quot;.</p><p align="justify">While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today.</p><p align="justify">The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said.</p><p align="justify">&quot;Intermittent therapy has been known to be associated with a higher proportion of disease relapse,&quot; said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research.</p><p align="justify">&quot;The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced.&quot;</p><p align="justify">An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago.</p><p align="justify">A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen.</p><p align="justify">The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills.</p><p align="justify">The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four.</p><p align="justify">&quot;When quality is assured, fixed-dose-combinations are preferable,&quot; said Swaminathan.</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Prod to govt for daily pills for TB patients

-The Telegraph New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment. Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse. A consortium of non-government health organisations has asked the Centre to swiftly phase out the thrice-a-week therapy, saying the delays in implementing the daily regimen suggest the government is giving more priority to logistics and cost than patients' interests. "We're asking for something that has been adopted by almost all countries but India," said Leena Menghaney, access campaign coordinator in India with Medecins Sans Frontieres (MSF), the international humanitarian agency. "We're wondering when the health ministry will roll this out." Most patients who develop TB for the first time need to be treated with a combination of four drugs for two months and a combination of two drugs for an additional four months to achieve a cure. Almost all those who seek private treatment - an estimated half of India's TB patients - are prescribed daily drug therapy. But the TB control programme hands over the pills to its patients thrice a week, practising "intermittent therapy". While the health ministry had last year signalled an intention to move to a daily regimen, there is no evidence on the ground for such a policy change yet, MSF and five other health organisations said in a media release today. The last round of procurement bids started by the government last September - over six months after the health ministry had released the TB treatment standards - did not reflect any move towards fixed-dose combinations for daily therapy, the organisations said. "Intermittent therapy has been known to be associated with a higher proportion of disease relapse," said Soumya Swaminathan, director of the Chennai-based Tuberculosis Research Centre, which functions under the Indian Council of Medical Research. "The programme has a relapse rate of 12 to 14 per cent, which needs to be reduced." An infectious disease specialist who requested not to be named said that signals of the need to shift from intermittent to daily therapy had emerged nearly 15 years ago. A technical report by the World Health Organisation had in 2000 cited medical studies that suggested the rate of relapse was about five per cent after daily therapy and 10 per cent after the intermittent regimen. The non-government health organisations have also urged the government to introduce fixed-dose-combinations - pills that combine two or three drugs - instead of the current practice of giving patients the four drugs as four different pills. The fixed-dose-combinations will reduce the number of pills patients have to swallow during the first two months of treatment from seven to eight each day to three to four. "When quality is assured, fixed-dose-combinations are preferable," said Swaminathan.